Kontigo Care AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0007075247
SEK
1.75
-0.11 (-5.91%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Kontigo Care AB stock-summary
stock-summary
Kontigo Care AB
Pharmaceuticals & Biotechnology
Kontigo Care AB is a Sweden-based company, which is primarily focused on advanced medical equipment industry. The Company operates as a provider of mobile solutions for the treatment of alcoholism. The Company develops TripleA which is a system of care for the treatment of alcoholism. The system consists of a wireless breathalyzer, an application and a health care portal. The portal creates patient care plan and shares it with health care provider. On the basis of this plan, the patient receives information about scheduled sobriety test. Test results are then sent back to the health care provider who can monitor the patient's sobriety every day. The Company operates domestically on the territory of Sweden.
Company Coordinates stock-summary
Company Details
Pavel Snickares Grand 12 , UPPSALA None : 753 20
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Ove Joanson
Chairman of the Board
Mr. Jan Fock
Vice Chairman of the Board
Ms. Agneta Bergvall
Director
Mr. Michael Collaros
Director
Mr. Juha Thumer
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
7 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 65 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.27

stock-summary
Return on Equity

-2.74%

stock-summary
Price to Book

1.26